Drug intelligence / Profile preview

feverfew

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Feverfew is a perennial herb (*Tanacetum parthenium*) from the Asteraceae family, traditionally used for centuries in European and Mediterranean herbal medicine. The main active compound is **parthenolide**, a sesquiterpene lactone concentrated in the leaves and flowers. Feverfew's best-studied and most common use is for the **prevention of migraine headaches**[1][2][3]. Its pharmacological effects derive primarily from anti-inflammatory and anti-platelet mechanisms, notably inhibiting the synthesis of prostaglandins, leukotrienes, and thromboxanes, as well as noncompetitive inhibition of serotonin-mediated vascular smooth muscle spasmogenesis. Other documented uses include management of **fevers, arthritis, menstrual irregularities, stomach aches, toothache, insect bites, and inflammatory skin diseases (e.g., psoriasis)**[1][3][5][6][8]. There is limited and mixed clinical evidence for most uses except migraine prophylaxis; preclinical and mechanistic data suggest wide-ranging anti-inflammatory, analgesic, antispasmodic, and antimicrobial effects, mainly attributable to parthenolide and flavonoid glycosides[1][2][3][5][6].

Other names
featherfewfebrifuge plantwild chamomilebachelor's buttonsmidsummer daisy
02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)PGHS-1 (Prostaglandin G/H Synthase 1)CHUK (IKKα)

Beyond the preview

Go deeper on feverfew.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on feverfew.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call